Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Postoperative Pain

In brief

This study will compare repeated intermittent IV dosing of diclofenac in patient with moderate to severe post-surgical pain from elective orthopedic surgery.

Key facts

Study ID

NCT00507026

Run by

Pfizer

People needed

277

Starts

2007-07-25

Expected to finish

2008-10-14

Last updated by the study team

2021-10-29

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled within three weeks of the screening visit to undergo elective orthopedic surgery.
• Moderate to severe pain within 6 hours following completion of the required surgery.

You may not qualify if…

• Chronic pain conditions.
• Chronic disease or recent cardiovascular events.
• Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.

Where it is running

• Helen Keller Hospital — Sheffield, Alabama, United States
• Arizona Research Center — Phoenix, Arizona, United States
• Accurate Clinical Trials — San Clemente, California, United States
• East Coast Clincial Research — Ft. Pierce, Florida, United States
• Outcomes Research Institute — Louisville, Kentucky, United States
• American Institute of Healthcare and Fitness — Raleigh, North Carolina, United States
• University Orthopedics Center — State College, Pennsylvania, United States
• SCIREX — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.